30
Jul
According to the company's filing on the Bombay Stock Exchange (BSE), Ecums Drugs & Pharmaceuticals Ltd said the company has raised about ₹828.78 crore from anchor investors ahead of its initial public offering on Tuesday, July 30.The pharmaceutical manufacturing company on Monday, July 29, allotted 1,22,05,912 or 1.22 crore equity shares to its anchor investors at ₹679 per share, according to exchange filings.These included SBI Healthcare Opportunities Fund, SBI Conservative Hybrid Fund, International Growth and Income Fund, Smallcap World Fund, Abu Dhabi Investment Authority, DSP India Fund, IIFL Asset Management Ltd, BlackRock Emerging Frontiers Master Fund Ltd, BlackRock Global Funds…
